These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
828 related articles for article (PubMed ID: 29117618)
1. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618 [TBL] [Abstract][Full Text] [Related]
2. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial. Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z J Diabetes Complications; 2017 Sep; 31(9):1394-1400. PubMed ID: 28716357 [TBL] [Abstract][Full Text] [Related]
3. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657 [TBL] [Abstract][Full Text] [Related]
5. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718 [TBL] [Abstract][Full Text] [Related]
6. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059 [TBL] [Abstract][Full Text] [Related]
7. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes. Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970 [TBL] [Abstract][Full Text] [Related]
8. Metabolic Response to Omega-3 Fatty Acids and Vitamin E Co-Supplementation in Patients with Fibrocystic Breast Disease: A Randomized, Double-Blind, Placebo-Controlled Trial. Mirhashemi SM; Sahmani M; Salehi B; Zavar Reza J; Taghizadeh M; Moussavi N; Badehnoosh B; Asemi Z Arch Iran Med; 2017 Aug; 20(8):466-473. PubMed ID: 28846009 [TBL] [Abstract][Full Text] [Related]
9. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385 [TBL] [Abstract][Full Text] [Related]
10. The Effects of Omega-3 Fatty Acids Supplementation on Gene Expression Involved in the Insulin and Lipid Signaling Pathway in Patients with Polycystic Ovary Syndrome. Nasri K; Hantoushzadeh S; Aghadavod E; Taghizadeh M; Asemi Z Horm Metab Res; 2017 Jun; 49(6):446-451. PubMed ID: 28235206 [TBL] [Abstract][Full Text] [Related]
11. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Maktabi M; Chamani M; Asemi Z Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140 [TBL] [Abstract][Full Text] [Related]
12. Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Vargas ML; Almario RU; Buchan W; Kim K; Karakas SE Metabolism; 2011 Dec; 60(12):1711-8. PubMed ID: 21640360 [TBL] [Abstract][Full Text] [Related]
13. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Taghizadeh M; Tamtaji OR; Dadgostar E; Daneshvar Kakhaki R; Bahmani F; Abolhassani J; Aarabi MH; Kouchaki E; Memarzadeh MR; Asemi Z Neurochem Int; 2017 Sep; 108():183-189. PubMed ID: 28342967 [TBL] [Abstract][Full Text] [Related]
14. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309 [TBL] [Abstract][Full Text] [Related]
15. The effects of Jamilian M; Tabassi Z; Reiner Ž; Panahandeh I; Naderi F; Aghadavod E; Amirani E; Taghizadeh M; Shafabakhsh R; Satari M; Mansournia MA; Memarzadeh MR; Asemi Z Br J Nutr; 2020 Apr; 123(7):792-799. PubMed ID: 31902378 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Jamilian M; Sabzevar NK; Asemi Z Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483 [TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862 [TBL] [Abstract][Full Text] [Related]
18. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649 [TBL] [Abstract][Full Text] [Related]
19. The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome. Jamilian M; Asemi Z J Clin Endocrinol Metab; 2016 Sep; 101(9):3386-94. PubMed ID: 27490918 [TBL] [Abstract][Full Text] [Related]
20. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Nasri K; Jamilian M; Rahmani E; Bahmani F; Tajabadi-Ebrahimi M; Asemi Z BMC Endocr Disord; 2018 Apr; 18(1):21. PubMed ID: 29649996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]